| 释义 |
Imatinib
基本例句
伊马替尼¹⁰⁰
Imatinibbinds to both KIT and ABL kinases.伊马替尼顶结合双方试剂盒和abl的激酶。
The patient underwent treatment with imatinib mesylate without response.病人接受甲磺酸伊马替尼治疗没有反应。
This clinical trial was the basis for the first approval of imatinib for CML, which has since become the standard of care for the disease.临床实验是最初批准伊马替尼用于慢性粒细胞性白血病的基础，后来伊马替尼成为了治疗这种疾病的标准。
Imatinibwas redesigned to produce WBZ_4 which binds to KIT and additionally JNK kinases, but not ABL.伊马替尼是重新设计制作wbz_4 由下而上 ，其中结合试剂盒和另外活性的激酶，但不大气边界层。
Imatinibis currently the most popular therapy for chronic myeloid leukemia .伊马替尼是目前治疗慢性髓细胞白血病的最普遍药物。 |